Physician profile
Shea E Hogan
NPI 1427175033
$3,287.11
in general payments reported to CMS, 2019-2025
13 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $909 · 2020: $1,363 · 2021: $254 · 2023: $20.99 · 2024: $625 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $1,360.95 | 2019-2020 | |
| Abbott Laboratories | $573.70 | 2019-2024 | Jeti All In One Non-Sterile Kit |
| Medtronic, INC. | $371.96 | 2021-2024 | Symplicity G3, Abre |
| Medtronic Vascular, INC. | $252.57 | 2019-2020 | |
| Novo Nordisk INC | $202.93 | 2021-2024 | |
| Boston Scientific Corporation | $154.17 | 2019-2023 | Angiojet Ultra 5000a |
| W. L. Gore & Associates, INC. | $113.43 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $104.92 | 2019-2025 | Lifevest |
| Abiomed | $63.84 | 2024 | Impella |
| Penumbra, INC. | $30.85 | 2025 | Penumbra System |
| Biotronik INC. | $23.12 | 2019 | |
| Terumo Medical Corporation | $20.82 | 2020 | |
| Philips North America LLC | $13.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shea Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.